Linkage mapping of canine rod cone dysplasia type 2 (rcd2) to CFA7, the canine orthologue of human 1q32

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 3, 2006, Pages 1210-1215

  Kukekova, Anna V ^a   Nelson, Jacquelyn ^a   Kuchtey, Rachel W ^b   Lowe, Jennifer K ^c   Johnson, Jennifer L ^a   Ostrander, Elaine A ^d   Aguirre, Gustavo D ^e   Acland, Gregory M ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; LEBER CONGENITAL AMAUROSIS; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; RETINITIS PIGMENTOSA; ROD CONE DYSPLASIA TYPE 2 GENE; ANIMAL; ANIMAL DISEASE; ATROPHY; CHROMOSOME; CHROMOSOME 1; CHROMOSOME MAP; DOG; DOG DISEASE; FEMALE; GENETICS; HUMAN; MALE; PATHOLOGY; PEDIGREE; PHOTORECEPTOR; RADIATION HYBRID MAPPING;

EYE PROTEIN; MEMBRANE PROTEIN;

ANIMALS; ATROPHY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, MAMMALIAN; DOG DISEASES; DOGS; EYE PROTEINS; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MEMBRANE PROTEINS; PEDIGREE; PHOTORECEPTORS, VERTEBRATE; RADIATION HYBRID MAPPING; RETINAL DEGENERATION;

EID: 33645389960     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0861     Document Type: Article

References (45)

1. Kijas JW, Cideciyan AV, Aleman TS, et al. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 2002;99:6328-6333.
2. Sidjanin DJ, Lowe JK, McElwee JL, et al. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002;11:1823-1833.
3. Benson KF, Li, F-Q, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet. 2003;35:90-96.
4. Lingaas F, Comstock KE, Kirkness EF, et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum Mol Genet. 2003;12:3043-3053.
5. Kirkness EF, Bafna V, Halpern AL, et al. The dog genome: survey sequencing and comparative analysis. Science. 2003;301:1898-1903.
6. Guyon R, Lorentzen TD, Hitte C, et al. A 1-Mb resolution radiation hybrid map of the canine genome. Proc Natl Acad Sci USA. 2003;100:5296-5301.
7. Breen M, Hitte C, Lorentzen TD, et al. An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics. 2004;5:65.
8. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98:365-376.
9. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;27:92-95.
10. Haskins M, Casal M, Ellinwood NM, Melniczek J, Mazrier H, Giger U. Animal models for mucopolysaccharidoses and their clinical relevance. Acta Paediatr Suppl. 2002;91:88-97.
11. Wolf ED, Vainisi SJ, Santos-Anderson R. Rod-cone dysplasia in the collie. J Am Vet Med A. 1978;173:1331-1333.
12. Santos-Anderson R, Tso M, Wolf E. An inherited retinopathy in collies: a light and electron microscopic study. Invest Ophthalmol Vis Sci. 1980;19:1281-1294.
13. Woodford B, Liu Y, Fletcher R, et al. Cyclic nucleotide metabolism in inherited retinopathy in collies: a biochemical and histochemical study. Exp Eye Res. 1982;34:703-714.
14. Acland GM, Gentleman S, Fletcher RT, Chader GJ, Aguirre GD. Nonallelism of 3 genes (rcd1, rcd2 and erd) for early onset hereditary retinal degeneration. Exp Eye Res. 1989;49:983-998.
15. Chader GJ, Fletcher RT, Sanyal S, Aguirre GD. A review of the role of cyclic GMP in neurological mutants with photoreceptor dysplasia. Curr Eye Res. 1985;4:811-819.
16. Aguirre GD, Lolley R, Farber D, Fletcher T, Chader G. Rod-cone dysplasia in Irish setter dogs: a defect in cyclic GMP metabolism in visual cells. Science. 1978;201:1133-1135.
17. Wang W, Acland GM, Ray K, Aguirre GD. Evaluation of cGMP- phosphodiesterase (PDE) subunits for causal association with rodcone dysplasia 2 (rcd2), a canine model of abnormal retinal cGMP metabolism. Exp Eye Res. 1999;69:445-453.
18. Aguirre G, Farber D, Lolley R, et al. Retinal degeneration in the dog. III. Abnormal cyclic nucleotide metabolism in rod-cone dysplasia. Exp Eye Res. 1982;35:625-642.
19. Wang W, Acland GM, Aguirre GD, Ray K. Cloning and characterization of the cDNA encoding the - subunit of cGMP-phosphodiesterase in canine retinal rod photoreceptor cells. Mol Vis. 1996;2:3.
20. Wang W, Acland GM, Aguirre GD, Ray K. Cloning and characterization of the cDNA and gene encoding the γ-subunit of cGMP-phosphodiesterase in canine retinal rod photoreceptor cells. Gene. 1996;181:1-5.
21. Wang W, Zhang Q, Acland GM, et al. Molecular characterization and mapping of canine cGMP-phosphodiesterase delta subunit (PDE6D). Gene. 1999;236:325-332.
22. Wang W. Molecular analysis of photoreceptor genes for causal association with rod cone dysplasia 2 (rcd2), a canine model of abnormal retinal cGMP metabolism. Ithaca, NY: Cornell University; 1999. PhD Thesis.
23. Ray K, Baldwin VJ, Zeiss C, Acland GM, Aguirre GD. Canine rod transducin α - 1: cloning of the cDNA and evaluation of the gene as a candidate for progressive retinal atrophy. Curr Eye Res. 1997;16:71-77.
24. Ray K, Wang W, Czarnecki J, Zhang Q, Acland GM, Aguirre GD. Strategies for identification of mutations causing hereditary retinal diseases in dogs: evaluation of opsin as a candidate gene. J Hered. 1999;90:133-137.
25. Akhmedov NB, Baldwin VJ, Zangerl B, et al. Cloning and characterization of the canine photoreceptor specific cone-rod homeobox (CRX) gene and evaluation as a candidate for early onset photoreceptor diseases in the dog. Mol Vis. 2002;8:79-84.
26. Gilbert JR, Vance JM. Isolation of genomic DNA from mammalian cells. In: Current Protocols in Human Genetics. New York: John Wiley and Sons; 1994;Appendix A.3B:1-6.
27. Matise TC, Perlin M, Chakravarti A. Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet. 1994;6:384-390.
28. Mellersh CS, Langston AA, Acland GM, et al. A linkage map of the canine genome. Genomics. 1997;46:326-336.
29. Acland GM, Ray K, Mellersh CS, et al. Linkage analysis and comparative mapping of canine progressive rod-cone degeneration (prcd) establishes potential locus homology with retinitis pigmentosa (RP17) in humans. Proc Natl Acad Sci USA. 1998;95:3048-3053.
30. Acland G, Ray K, Mellersh C, et al. A novel retinal degeneration locus identified by linkage and comparative mapping of canine early retinal degeneration. Genomics. 1999;59:134-142.
31. Vignaux F, Hitte C, Priat C, Chuat JC, Andre C, Galibert F. Construction and optimization of a dog whole-genome radiation hybrid panel. Mamm Genome. 1999;10:888-894.
32. den Hollander AI, ten Brink JB, de Kok YJM, et al. Mutations in a human homologue of Drosophila crumbs cause retinitis pigmentosa (RP12). Nat Genet. 1999;23:217-221.
33. den Hollander AI, van Driel MA, de Kok YJ, et al. Isolation and mapping of novel candidate genes for retinal disorders using suppression subtractive hybridization. Genomics. 1999;58:240-249.
34. Danciger JS, Danciger M, Nusinowitz S, Rickabaugh T, Farber DB. Genetic and physical maps of the mouse rd3 locus; exclusion of the ortholog of USH2A. Mamm Genome. 1999;10:657-661.
35. Zhang Q, Acland GM, Wu WX, et al. Different RPGR exon ORF15 mutations in Canids provide insights into photoreceptor cell degeneration. Hum Mol Genet. 2002;11:993-1003.
36. Dejneka NS, Rex TS, Bennett J. Gene therapy and animal models for retinal disease. Dev Ophthalmol. 2003;37:188-198.
37. Rex TS, Allocca M, Domenici L, et al. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther. 2004;10:855-861.
38. Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2002;43:3292-3298.
39. Tschernutter M, Schlichtenbrede FC, Howe S, et al. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther. 2005;12:694-701.
40. Van Hooser JP, Liang Y, Maeda T, et al. Recovery of visual functions in a mouse model of Leber congenital amaurosis. J Biol Chem. 2002;277:19173-19182.
41. Vollrath D, Feng W, Duncan JL, et al. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci USA. 2001;98:12584-12589.
42. Ali RR. Prospects for gene therapy. Novartis Found Symp. 2004;255:165-172.
43. Hauswirth WW, Li Q, Raisler B, Timmers AM, et al. Range of retinal diseases potentially treatable by AAV-vectored gene therapy. Novartis Found Symp. 2004;255:179-194.
44. Rolling F. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Gene Ther. 2004;11(suppl 1):S26-S32.
45. Weleber RG, Kurz DE, Trzupek KM. Treatment of retinal and choroidal degenerations and dystrophies: current status and prospects for gene-based therapy. Ophthalmol Clin North Am. 2003;16:583-593. AQ1: Table has been typeset by a compositor. Please verify all information.